MT 4 McNEIL Pill - yellow clear capsule/oblong, 15mm
Generic Name: pancrelipase
Pill with imprint MT 4 McNEIL is Yellow / Clear, Capsule/Oblong and has been identified as Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease. It is supplied by Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Pancreaze is used in the treatment of Pancreatic Exocrine Dysfunction; Chronic Pancreatitis; Cystic Fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).
Images for MT 4 McNEIL
Pancreaze
- Generic Name
- pancrelipase
- Imprint
- MT 4 McNEIL
- Strength
- 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease
- Color
- Yellow / Clear
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Digestive enzymes
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ortho-McNeil-Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0341 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
silicon dioxide,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
triethyl citrate,
magnesium silicate,
dimethicone,
gelatin,
titanium dioxide,
sodium lauryl sulfate,
sorbitan monolaurate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "MT 4 McNEIL"
More about Pancreaze (pancrelipase)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: digestive enzymes
- Breastfeeding
- En español
Patient resources
Other brands
Creon, Zenpep, Viokace, Pertzye, ... +3 more
Professional resources
Other brands
Creon, Zenpep, Viokace, Pertzye
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.